FABRIZIO, FEDERICO PIO
FABRIZIO, FEDERICO PIO
Dipartimento di Oncologia ed Emato-Oncologia
B7-H3/CD276 and small-cell lung cancer: What's new?
2024 F. Fabrizio, L. Muscarella, A. Rossi
circPVT1 and PVT1/AKT3 show a role in cell proliferation, apoptosis, and tumor subtype-definition in small cell lung cancer
2023 D. Tolomeo, D. Traversa, S. Venuto, K.K. Ebbesen, J.L. Garcia Rodriguez, G. Tamma, M. Ranieri, G. Simonetti, M. Ghetti, M. Paganelli, G. Visci, A. Liso, K. Kok, L.A. Muscarella, F.P. Fabrizio, M.A. Frassanito, A. Lamanuzzi, I. Saltarella, A.G. Solimando, A. Fatica, Z. Ianniello, R.M. Marsano, A. Palazzo, A. Azzariti, V. Longo, S. Tommasi, D. Galetta, A. Catino, A. Zito, T. Mazza, A. Napoli, G. Martinelli, J. Kjems, L.S. Kristensen, A. Vacca, C.T. Storlazzi
Monitoring EGFR-lung cancer evolution: a possible beginning of a "methylation era" in TKI resistance prediction
2023 F. Fabrizio, A. Sparaneo, L. Muscarella
Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
2022 R. Mokhtari, B. Qorri, N. Baluch, A. Sparaneo, F. Fabrizio, L. Muscarella, A. Tyker, S. Kumar, H. Cheng, M. Szewczuk, B. Das, H. Yeger
Design and experimental validation of OPERA_MET-A panel for deep methylation analysis by next generation sequencing
2022 F.P. Fabrizio, S. Castellana, F. Centra, A. Sparaneo, M. Mastroianno, T. Mazza, M. Coco, D. Trombetta, N. Cingolani, A. Centonza, P. Graziano, E. Maiello, V.M. Fazio, L.A. Muscarella
Next-generation multimodality of nutrigenomic cancer therapy: Sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
2021 R.B. Mokhtari, B. Qorri, N. Baluch, A. Sparaneo, F.P. Fabrizio, L.A. Muscarella, A. Tyker, S. Kumar, H.-.M. Cheng, M.R. Szewczuk, B. Das, H. Yeger
NRG1 and NRG2 fusions in non-small cell lung cancer (NSCLC): seven years between lights and shadows
2021 D. Trombetta, A. Sparaneo, F.P. Fabrizio, C.M. Di Micco, A. Rossi, L.A. Muscarella
Mixed Pulmonary Adenocarcinoma and Atypical Carcinoid: A Report of Two Cases of a Non-codified Entity With Biological Profile
2021 P. Parente, A. Rossi, A. Sparaneo, F.P. Fabrizio, A. Centonza, M. Taurchini, T. Mazza, M. Cassano, G. Miscio, F. Centra, G.M. Ferretti, C.M. Di Micco, P. Graziano, L.A. Muscarella
Neuroendocrine-Related Circulating Transcripts in Small-Cell Lung Cancers: Detection Methods and Future Perspectives
2021 L. Anna Muscarella, T. Mazza, F.P. Fabrizio, A. Sparaneo, V. D’Alessandro, A. Tancredi, D. Trombetta, F. Centra, S. Pia Muscarella, C. Martina Di Micco, A. Rossi
NRF2 regulation by noncoding RNAs in cancers: The present knowledge and the way forward
2020 F.P. Fabrizio, A. Sparaneo, L.A. Muscarella
Potential Prognostic Role of SPARC Methylation in Non-Small-Cell Lung Cancer
2020 F.P. Fabrizio, A. Sparaneo, A. Fontana, T. Mazza, P. Graziano, A. Pantalone, P. Parente, F. Centra, N. Orlando, D. Trombetta, A. Torre, G.M. Ferretti, M. Taurchini, C.M.D. Micco, E. Maiello, V.M. Fazio, A. Rossi, L.A. Muscarella
Identification of EML4-ALK fusion in a sporadic case of cholangiocarcinoma
2020 D. Trombetta, P. Parente, T.P. Latiano, F.P. Fabrizio, L.A. Muscarella
Epigenetic scanning of keap1 cpg sites uncovers new molecular-driven patterns in lung adeno and squamous cell carcinomas
2020 F.P. Fabrizio, T. Mazza, S. Castellana, A. Sparaneo, L.A. Muscarella
Epigenetic Silencing of SPARC in NSCLCs
2019 F. Fabrizio, A. Sparaneo, A. Rossi, A. Pantalone, A. Fontana, F. Centra Fiordelisi, N. Orlando, P. Graziano, D. Trombetta, V. Fazio, L. Muscarella
Comparison of Molecular Testing Modalities for Detection of NRG1 Rearrangements in Invasive Mucinous Adenocarcinoma
2019 D. Trombetta, F. Fabrizio, P. Graziano, G. Rossi, M. Manzorra, A. Sparaneo, F. Cento, A. Rossi, M. Tiseo, L. Gnetti, M. Di Maio, E. Maiello, V. Fazio, L. Muscarella
REDOXI-miRNA of Keap1/Nrf2 axis in lung tumors
2019 F.P. Fabrizio, A. Sparaneo, S. Castellana, T. Mazza, D. Trombetta, P. Graziano, A. Rossi, V.M. Fazio, L.A. Muscarella
Effects of KEAP1 silencing on the regulation of NRF2 activity in neuroendocrine lung tumors
2019 A. Sparaneo, F.P. Fabrizio, A. la Torre, P. Graziano, M. Di Maio, A. Fontana, M. Bisceglia, A. Rossi, S. Pizzolitto, G. De Maglio, A. Tancredi, F. Grimaldi, T. Balsamo, F. Centra, M.C. Manzorra, D. Trombetta, A. Pantalone, A. Bonfitto, E. Maiello, V.M. Fazio, L.A. Muscarella
Automated workflow for somatic and Germline next generation sequencing analysis in routine clinical cancer diagnostics
2019 L.A. Muscarella, F.P. Fabrizio, M. De Bonis, M.T. Mancini, T. Balsamo, P. Graziano, F. Centra, A. Sparaneo, D. Trombetta, A. Bonfitto, V. Scagliusi, P. Larizza, E.D. Capoluongo, V.M. Fazio
Methylation density pattern of keap1 gene in lung cancer cell lines detected by quantitative methylation specific PCR and pyrosequencing
2019 F.P. Fabrizio, A. Sparaneo, F. Centra, D. Trombetta, C.T. Storlazzi, P. Graziano, E. Maiello, V.M. Fazio, L.A. Muscarella
Epigenetic versus genetic deregulation of the KEAP1/NRF2 axis in solid tumors: Focus on methylation and noncoding RNAs
2018 F.P. Fabrizio, A. Sparaneo, D. Trombetta, L.A. Muscarella